Skip to main content
CIN- L67120MH1995PLC084899
 

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Parmax Pharma Ltd.

NSE : BSE : 540359 ISIN CODE : INE240T01014Industry : Pharmaceuticals

News

  • Parmax Pharma - Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The Company 23 Jun 2026 | 19:26 | Dion Global

    Corrigendum to the EGM Notice dated 8th June 2026more...

  • Parmax Pharma - Draft Letter of Offer 23 Jun 2026 | 08:46 | Dion Global

    Fedex Securities Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Share...more...

  • Parmax Pharma - Detailed Public Statement 15 Jun 2026 | 18:34 | Dion Global

    Fedex Securities Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read wi...more...

  • Parmax Pharma - EGM Scheduled To Be Held On July 02, 2026 09 Jun 2026 | 23:03 | Dion Global

    Notice of EGM scheduled to be held on July 02 2026more...

  • Parmax Pharma - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 09 Jun 2026 | 22:52 | Dion Global

    Share purchase agreement and Public Announcementmore...

  • Parmax Pharma - Open Offer 09 Jun 2026 | 08:51 | Dion Global

    Fedex Securities Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Public Announcement under Regulation 3(1) And Regulation 4 ...more...

  • Parmax Pharma - Board Meeting Outcome for Outcome Of Board Meeting 08 Jun 2026 | 15:23 | Dion Global

    Issue of Shares and Warrants on Preferential basis pursuant to SEBI ICDR Regulationsmore...

  • Parmax Pharma - Board Meeting Intimation for Fund Raising 03 Jun 2026 | 21:17 | Dion Global

    Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2026 inter alia to conside...more...

  • Parmax Pharma - Results-Delay in Financial Results 03 Jun 2026 | 19:06 | Dion Global

    Results for Financial Results for Quarter and Financial Year ended March 31 2026more...

  • Parmax Pharma - Board Meeting Outcome for Outcome Of Board Meeting 03 Jun 2026 | 18:45 | Dion Global

    Reschedule of Boar Meeting and Outcome of Board Meetingmore...

  • Parmax Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM 31 May 2026 | 21:04 | Dion Global

    Proceedings of EGM held on May 27 2026more...

  • Parmax Pharma - Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended Marc 31, 2026 30 May 2026 | 22:06 | Dion Global

    Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/06/2026 inter alia to conside...more...

  • Parmax Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report 28 May 2026 | 22:06 | Dion Global

    Scrutinizer Reportmore...

  • Parmax Pharma - Board Meeting Intimation for Considering Audited Financial Results Of Quarter And Financial Year Ended On Mar 27 May 2026 | 22:33 | Dion Global

    Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to conside...more...

  • Parmax Pharma - Extra Ordinary General Meeting Scheduled To Be Held On May 27, 2026 04 May 2026 | 19:20 | Dion Global

    Notice of Extra-ordinary General Meeting of the Company scheduled to be held on May 27 2026more...

  • Parmax Pharma - Announcement under Regulation 30 (LODR)-Change in Management 02 May 2026 | 17:59 | Dion Global

    Re-appointment of Mr. Umang Gosalia as a Managing Director of the Companymore...

  • Parmax Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr 2026 | 17:50 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Parmax Pharma Ltd...more...

  • Parmax Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 21 Apr 2026 | 17:00 | Dion Global

    As of March 2026 30.80% is owned by Indian Promoters and 69.20% by Public. Top three Promoters holding highest number of shares of Parmax Ph...more...

  • Parmax Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 17 Apr 2026 | 10:25 | Dion Global

    RTA Compliance certificate for Quarter ended March 31 2026more...

  • Parmax Pharma - Appointment of Company Secretary and Compliance Officer 25 Mar 2026 | 11:20 | Dion Global

    Appointment of Ms. Bhakti Aghera as a Company Secretarymore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex77100.470.14%
NSE Index240560.14%
B500DIVL503456.96-1.13%
BSE 1000 10805.18-0.08%
BSE 100LCTMC9058.380.14%
BSE Auto 59666.962.29%

Commodity

Gold1398430.00%
Silver2186800.00%
Copper1291.85216.79%
Crude Oil67955.96%
Lead207.754.54%
Mentha Oil1093.72.46%
Nickel1624.5111.83%

Currency

USD/INR 94.70(0.00 %)
GBP/INR 124.93(-0.36 %)
EUR/INR 107.63(-0.52 %)
JPY/INR 0.59(0.71 %)
CAD/INR 66.73(0.13 %)
HKD/INR 12.05(-0.23 %)


Announcement Calendar

Upcoming

BOARD MEETINGS
Company Name : Supreme Infra. India
Date : 04-07-2026